We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Shares of Equifax Inc. EFX shed 2.64% to $267.52 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Equifax (EFX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...

Leerink Partners analyst Thomas Smith adjusted the price target for 89bio Inc . (NASDAQ:ETNB) to $37 from $34, while ...

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Airbus Group SE (EADSF – Research Report) and Equifax ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Check the time stamp on this data. Updated AI-Generated Signals for Equifax Inc. (EFX) available here: EFX. Type a few ...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll ...

Shares of Equifax Inc. EFX slid 1.28% to $274.78 Friday, on what proved to be an all-around grim trading session for the ...

Akero Therapeutics (AKRO) stock was upgraded by Bank of America based on Phase 2 data the company shared for its liver disorder drug, efruxifermin. Read more here.

As the U.S. stock market navigates a period of volatility marked by the Federal Reserve's decision to maintain interest rates and investor focus on major tech earnings, identifying undervalued stocks ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...